Applications will be open from 1 July 2021 at 9 am ACST and be closed at 30 July 2021 at 4 pm ACST.

Photo by Nathan Anderson on Unsplash.

Expressions of interest close 19 April 2021.

Minimum Data: 5pm ACT local time on 7 July 2021

Expressions of interest close 10 March 2021

Strategic investment in data registries, biobanks and data linkage platforms for primary health care in a range of settings. 

• Maternal health 
• Early childhood, or 
• Exercise and nutrition.

Projects should aim to improve medicine use and medicine intervention by pharmacists in primary health and transitions of care.

• Stream 1-Cancer in children
• Stream 2-Cancer in adolescents

Clinical trial in Australia, in collaboration with international counterparts. 

Stream 1: utilise existing evidence to develop or improve approaches for the early diagnosis of ovarian cancer, cancers of the pancreas, liver cancer or lung cancer that have a clinically feasible pathway to implementation

Stream 2: enable approaches for the early diagnosis of cancers with unknown primary site that have a clinically feasible pathway to implementation. 

Development of novel interventions, including therapeutics and devices, to prevent cardiovascular disease and stroke; develop novel treatments and devices to improve outcomes; and conduct small-scale development projects to establish feasible, evidence-based approaches aimed at improving survivorship and reducing morbidity.

$17.5 million across 4 streams.